SANTA CLARA, Calif. – Agilent Technologies, Inc. (NYSE: A) today announced Simon May has been named president of the company’s Diagnostics and Genomics Group (DGG). May, previously executive vice president and president of the Life Science Group at Bio-Rad Laboratories, will join Agilent on May 6. “We are excited to welcome Simon May to the Agilent team,” […]

MINNEAPOLIS — Bio-Techne Corporation (NASDAQ: TECH), a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities is pleased to announce a significant milestone in its commitment to providing cutting-edge solutions to its customers. Effective May 1, 2024, Bio-Techne will enter into a strategic distribution agreement with Thermo Fisher Scientific, […]

SAN FRANCISCO — MiLaboratories, a leader in RNA immune technologies, and Miltenyi Biotec, a global pioneer in biotechnology, are excited to announce a landmark partnership that promises to revolutionize the field of next-generation therapies. This collaboration combines MiLaboratories’ cutting-edge RNA kit technology for immune sequencing with Miltenyi Biotec’s robust production and commercialization capabilities. Under this […]

AcouSort AB (“AcouSort”) and GenSensor SAS (“GenSensor”) today announce that the two companies have signed a Letter of Intent to integrate AcouSort’s acoustofluidics technology with GenSensor’s biology first Process Analytical Technology to accelerate bioprocess design and improve monitoring systems for bioreactor culturing. AcouSort and GenSensor share a common interest in providing the healthcare market with […]

HERCULES, Calif. — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced the promotion of James J. Barry, currently Senior Vice President of Global Manufacturing, to the position of Executive Vice President and President of the Life Science Group, effective May 1, 2024. He […]

Combination of leading nanopore sequencing technology with cloud-based SAAS analysis platform will help microbiologists gain critical infectious disease insights from genomic data OXFORD, UK — Oxford Nanopore Technologies (Oxford Nanopore) the company behind a new generation of molecular sensing technology based on nanopores, and BugSeq, a leading provider of fully automated infectious disease bioinformatics services, […]

PanOmiQ completes Whole Genome Sequencing analysis with a clinical report in 7 hours.   CALGARY, AB – BioAro, a pioneer in genomic research and technology, is set to officially launch PanOmiQ, a revolutionary software that will redefine the landscape of genomic analysis globally by providing real-time insights into the complexities of the human genome. With unparalleled speed, precision, and […]

EchoLUTION Tissue RNA Kit is suitable for the extraction of a variety of tissues.  Simple and fast extraction with a highly pure RNA outcome.  Sustainable option eliminating the need to use phenol/chloroform . BioEcho Life Sciences, the biotechnology company supplying fast and sustainable nucleic acid extraction technologies, has launched its latest product: the EchoLUTION Tissue RNA […]

New protocol for use in infectious disease research part of packed activity lineup for ESCMID Global 2024 OXFORD, UK — Oxford Nanopore Technologies (Oxford Nanopore), the company behind a new generation of molecular sensing technology based on nanopores, today announced its lineup of speakers and conference activities for the upcoming annual meeting of the European […]

Oxford, UK – Oxford Nanopore Technologies (Oxford Nanopore) today announced the launch of its Compatible Products Programme, a new initiative designed to establish and showcase approved compatible third-party products, ensuring seamless use in combination with Oxford Nanopore’s sequencing products. The programme will expand the network of products compatible with Oxford Nanopore’s platform to enhance the overall […]